About Manipal Health Enterprises Ltd IPO

Manipal Health Enterprises Ltd. is one of India’s leading healthcare service providers, operating a wide network of multi-speciality hospitals, clinics, and diagnostic centres across the country. Part of the Manipal Group, founded by T. M. A. Pai, the company focuses on delivering advanced and patient-centric healthcare services.

The company offers tertiary and quaternary care services across specialties such as oncology, cardiology, neurology, orthopaedics, organ transplants, and preventive healthcare. Its hospitals are equipped with advanced medical infrastructure and experienced healthcare professionals. 

Manipal Health continues to expand its presence through acquisitions, partnerships, and investments in medical infrastructure and digital healthcare initiatives.

Manipal Health Enterprises IPO Subscription Breakdown

Investory CategorySubscription PercentageAmount Raised (₹ Crores)
Qualified Institutional Buyers (QIBs)75%12,33,75,553.5 crores
Non-Institutional Investors (NIIs)15%2,46,75,110.7 crores
Retail Individual Investors (RIIs)10%1,64,50,073.8 crores

Manipal Health Enterprises IPO Strengths & Weaknesses

  • One of India’s largest multi speciality hospital networks by bed capacity

  • Strong leadership presence across key metro markets

  • Well-recognised healthcare brand with wide patient reach

  • Advanced medical infrastructure and focus on clinical excellence

  • Strong growth track record supported by operational efficiency

Manipal Health Enterprises IPO Important Dates & Issue Details

Allotment DateListing DateRefund Date
03 Aug '2605 Jul '2604 Aug '26
Issue Composition:
Face Value2 per share
Total Issue Size16,45,00,738 shares (aggregating up to ₹14,750 crores)
Fresh Issue6,77,96,610 shares (aggregating up to ₹13,55,93,220 crores)
Offer for Sale1,08,06,917 shares of ₹2 (aggregating up to ₹2,16,13,834 crores)
Issue TypeBook Building IPO
Post-Issue Shareholding Pattern:
Pre-Issue Shareholding81.43 shares
Post-Issue Shareholding72.08 shares

Manipal Health Enterprises IPO Lot Size and Investment Details

Minimum Lot Size25 shares
Maximum Lot Size (Retail)825 shares

The lot size of Manipal Health Enterprises ipo has been designed to ensure broad participation while maintaining optimal price discovery.

How to Apply for Manipal Health Enterprises IPO

  1. Log in to your Choice account
  2. Select IPO
  3. Enter the number of lots and your price
  4. Verify UPI ID
  5. Complete the transaction on your UPI app

Manipal Health Enterprises IPO Contact & Registrar Details

Contact Details

Address

Address

The Annexe, #98/2, Rustom Bagh, HAL Airport Road, Bengaluru

Phone Number

Phone Number

+91 80 4936 0300

Registrar Details

Address

Registrar Name

Kfin Technologies Ltd.

Phone Number

Phone Number

+91 04079615565

Optivalue Tek Consulting Ltd IPO Lead Manager(s)

Book Running Lead Manager(s)
Kotak Mahindra Capital Co Ltd | Axis Capital Ltd | Goldman Sachs (India) Securities Pvt Ltd

Manipal Health Enterprises IPO FAQs

The minimum lot size is 25 shares with a price band of ₹560 to ₹590 per share, requiring a minimum investment of ₹14,750.

Check allotment status on the registrar's website using PAN number or application number after the Manipal Health Enterprises IPO allotment date.

The listing date of Manipal Health Enterprises IPO is scheduled for 05 Jul '26 on NSE.

Investment decisions should be based on your risk appetite, financial goals, and a thorough analysis of the company's fundamentals and growth prospects.

Consider factors like company fundamentals, valuation, market conditions, and your investment portfolio before making any investment decision.

You can Manipal Health Enterprises IPO apply online through your broker's trading platform, mobile app, or through the ASBA facility via internet banking.

The Manipal Health Enterprises IPO allotment date and listing date are 03 Aug '26and 05 Jul '26, respectively.

Yes, you can apply through your bank's internet banking portal. The funds will remain in your account until allotment, and no need for separate IPO funding.